# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 134: Amendment to Schedule 1

Extent: E+W+S+N.I.

In Schedule 1 (further provisions for classification of medicinal products)—
(a) in paragraph 1—
(i) in sub-paragraph (e)(i), omit “, EU marketing authorisation”;
(ii) in sub-paragraph (f)(i), omit “, EU marketing authorisation”;
(iii) in sub-paragraph (g)(i), omit “, EU marketing authorisation”;
(b) in paragraph 4, omit “, EU marketing authorisation”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/134 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-134
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.